Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response.

[1]  A. Zuckerman,et al.  Vaccine-induced escape mutant of hepatitis B virus , 1990, The Lancet.

[2]  P. Ashton‐Rickardt,et al.  Mutants of the hepatitis b virus surface antigen that define some antigenically essential residues in the immunodominant a region , 1989, Journal of medical virology.

[3]  J Waters,et al.  Virus-neutralizing antibodies to hepatitis B virus: the nature of an immunogenic epitope on the S gene peptide. , 1986, The Journal of general virology.

[4]  H. Thomas,et al.  Neutralization of Hepatitis B Virus Infectivity by a Murine Monoclonal Antibody: An Experimental Study in the Chimpanzee , 1985, Journal of medical virology.

[5]  F. Deinhardt,et al.  CLINICAL EVALUATION OF A RECOMBINANT HEPATITIS B VACCINE , 1984, The Lancet.

[6]  A. Zuckerman,et al.  Determination of the affinity of antibodies to hepatitis B surface antigen in human sera. , 1984, Journal of immunological methods.

[7]  W. Gerlich,et al.  Structural Relationships Between Minor and Major Proteins of Hepatitis B Surface Antigen , 1983, Journal of virology.

[8]  A. Goodall,et al.  A rapid one-step radiometric assay for hepatitis B surface antigen utilizing monoclonal antibodies. , 1982, Journal of immunological methods.

[9]  A. J. Zuckerman,et al.  Hepatitis B polypeptide vaccine preparation in micelle form , 1981, Nature.

[10]  V. Zurawski,et al.  High affinity monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids. , 1981, Gastroenterology.

[11]  R. Purcell,et al.  Type B hepatitis: a review of current prospects for a safe and effective vaccine. , 1980, Reviews of infectious diseases.

[12]  A. Zuckerman,et al.  Analysis of hepatitis B surface antigen components solubilized with Triton X-100. , 1979, The Journal of general virology.

[13]  D. Margulies,et al.  A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells , 1977, Somatic cell genetics.

[14]  A. Williams,et al.  Concurrently circulating hepatitis B surface antigen and heterotypic anti-HBs antibody. , 1976, Journal of immunology.

[15]  D. Koziol,et al.  The development of HBsAg-positive hepatitis despite the previous existence of antibody to HBsAg. , 1976, Journal of immunology.

[16]  R. Purcell,et al.  Characterization of antibodies to the structural polypeptides of HGSAg: evidence for subtype-specific determinants. , 1976, Journal of immunology.

[17]  C. Milstein,et al.  Fusion between immunoglobulin‐secreting and nonsecreting myeloma cell lines , 1976, European journal of immunology.

[18]  S. Kurashina,et al.  Antigenicity of reduced and alkylated Australia antigen. , 1974, Journal of immunology.

[19]  G. Bouvier.  The heterogeneity of Australia antigen. , 1971 .

[20]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[21]  F. Dixon,et al.  A method of trace iodination of proteins for immunologic studies. , 1966, International archives of allergy and applied immunology.

[22]  C. Howard,et al.  Synthetic peptides: a next generation of vaccines? , 1987, Immunology today.

[23]  R. Kennedy,et al.  Characterization of anti-hepatitis B surface antigen monoclonal antibodies. , 1983, Intervirology.